Cargando…
Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS
OBJECTIVE: To evaluate relapse rates and disease-modifying drug (DMD) treatment in US women with multiple sclerosis (MS) and a live birth. METHODS: This retrospective administrative claims database study used US commercial health plan data from women with MS and a live birth from January 1, 2006, to...
Autores principales: | Houtchens, Maria K., Edwards, Natalie C., Phillips, Amy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205686/ https://www.ncbi.nlm.nih.gov/pubmed/30266887 http://dx.doi.org/10.1212/WNL.0000000000006382 |
Ejemplares similares
-
Pregnancy rates and outcomes in women with and without MS in the United States
por: Houtchens, Maria K., et al.
Publicado: (2018) -
MRI activity in MS and completed pregnancy: Data from a tertiary academic center
por: Houtchens, Maria, et al.
Publicado: (2020) -
Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS
por: Anderson, Annika, et al.
Publicado: (2021) -
Pregnancy does not modify the risk of MS in genetically susceptible women
por: Adams, Cameron J., et al.
Publicado: (2020) -
Outcome of MS relapses in the era of disease-modifying therapy
por: Stoppe, Muriel, et al.
Publicado: (2017)